Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The Latin America GI endoscopy market will grow moderately during the forecast period because of the improving access to healthcare across the region and the concerted efforts of health systems to implement extensive screening programs, especially for CRC. Having said that, the unstable economic conditions in the region, as well as the practice of reusing GI endoscopy devices among health care facilities, will act as limiting factors for the market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in Latin America across a 10-year period.
Few Latin American countries have extensive CRC screening programs.
In countries with such screening programs, what impact do these programs have on GI endoscopy procedure volumes?
What are other major factors affecting procedure volume growth in these countries?
The videoscope system market will grow moderately during the forecast period in Latin America.
What are the factors that will limit the growth of this market?
Which country will purchase the greatest number of videoscopes during the forecast period?
The ERCP device and biopsy device markets continue to make up a small proportion of the total market size.
How will device reuse affect revenue growth in these markets?
How will ERCP and biopsy procedure volumes be impacted by epidemiological trends and public participation in screening programs for common GI diseases?
Already a Client? Log in to access this report.
Raghav Tangri is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in facial injectables, hernia repair, and open surgery device markets; he has been featured in the Aesthetics Journal and has participated in several white papers and medtech blogs, with a specific focus on the Indian medical device industry. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London.